SEC Form 4 · accession 0001209191-15-039935
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore H Stanley
Director
Period of report
May 5, 2015
Accepted (ET)
May 7, 2015 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $53.50 | May 5, 2015 | A | 9,000 | A | — | May 4, 2025 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1The option shall vest in 36 equal monthly installments until fully vested and exercisable on May 5, 2018.